Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study

Yuedi Hu,1,2 Jian Liu,1,3,4 Ling Xin,3,4 Lei Wan,1,3,4 Yajun Qi,1 Yang Li,1 Yiming Chen1 1Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 2College of Chinese Medicine, Anhui University of Chinese Medicine, H...

Full description

Bibliographic Details
Main Authors: Hu Y, Liu J, Xin L, Wan L, Qi Y, Li Y, Chen Y
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/huangqin-qingre-chubi-capsule-is-associated-with-reduced-risk-of-readm-peer-reviewed-fulltext-article-IJGM
_version_ 1827782693444648960
author Hu Y
Liu J
Xin L
Wan L
Qi Y
Li Y
Chen Y
author_facet Hu Y
Liu J
Xin L
Wan L
Qi Y
Li Y
Chen Y
author_sort Hu Y
collection DOAJ
description Yuedi Hu,1,2 Jian Liu,1,3,4 Ling Xin,3,4 Lei Wan,1,3,4 Yajun Qi,1 Yang Li,1 Yiming Chen1 1Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 2College of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 3Institute of Rheumatology, Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 4Department of Internal Medicine Application Foundation Research and Development, Anhui Province—Key Laboratory of Modern Chinese Medicine, Hefei, Anhui, People’s Republic of ChinaCorrespondence: Jian Liu, Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, People’s Republic of China, Tel +86 13955109537, Email liujianahzy@126.comPurpose: The therapeutic effects of Huangqin Qingre Chubi (HQC) in rheumatoid arthritis (RA) have been documented. However, there is a lack of real-world clinical evidence supporting its efficacy.Methods: Patients diagnosed with RA were recruited from the First Affiliated Hospital of the Anhui University of Chinese Medicine. Patient information was obtained from the hospital’s database. Propensity score matching (PSM), Kaplan–Meier curve, and Cox proportional hazards model were used to control confounding factors and analyze the factors influencing readmission. Association rule analysis and random walk evaluation models were used to evaluate the correlations among HQC treatment, inflammation indicators, and self-perception of patients (SPP) scale.Results: After PSM, 3423 patients were enrolled, with 1142 in the HQC group and 2281 in the non-HQC group. The readmission risk of the HQC group was significantly lower than that of the non-HQC group. Combined univariate and multivariate analysis results revealed that risk factors for readmission were age > 60 years, female sex, hypertension, chronic gastritis, and elevated levels of laboratory indices, including anticyclic citrullinated peptide and complement component 3 (C3) and C4. HQC, disease-modifying antirheumatic drugs, nonsteroidal anti-inflammatory drugs, and glucocorticoid therapy were protective factors for readmission. HQC treatment was closely associated with improvements in many factors, including erythrocyte sedimentation rate, C-reactive protein, C3, rheumatoid factor levels, visual analog scale, depression self-assessment scale, and patient-reported activity index scores with RA.Conclusion: HQC treatment can reduce the risk of readmission and significantly improve immune inflammatory indicators and SPP in patients with RA, with no risk of hepatorenal toxicity.Keywords: Huangqin Qingre Chubi capsule, traditional Chinese medicine, rheumatoid arthritis, readmission
first_indexed 2024-03-11T15:36:42Z
format Article
id doaj.art-e43df757157c4184863d9db8e512d322
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-03-11T15:36:42Z
publishDate 2023-10-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-e43df757157c4184863d9db8e512d3222023-10-26T17:06:53ZengDove Medical PressInternational Journal of General Medicine1178-70742023-10-01Volume 164819483487630Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort StudyHu YLiu JXin LWan LQi YLi YChen YYuedi Hu,1,2 Jian Liu,1,3,4 Ling Xin,3,4 Lei Wan,1,3,4 Yajun Qi,1 Yang Li,1 Yiming Chen1 1Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 2College of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 3Institute of Rheumatology, Anhui University of Chinese Medicine, Hefei, Anhui, People’s Republic of China; 4Department of Internal Medicine Application Foundation Research and Development, Anhui Province—Key Laboratory of Modern Chinese Medicine, Hefei, Anhui, People’s Republic of ChinaCorrespondence: Jian Liu, Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, People’s Republic of China, Tel +86 13955109537, Email liujianahzy@126.comPurpose: The therapeutic effects of Huangqin Qingre Chubi (HQC) in rheumatoid arthritis (RA) have been documented. However, there is a lack of real-world clinical evidence supporting its efficacy.Methods: Patients diagnosed with RA were recruited from the First Affiliated Hospital of the Anhui University of Chinese Medicine. Patient information was obtained from the hospital’s database. Propensity score matching (PSM), Kaplan–Meier curve, and Cox proportional hazards model were used to control confounding factors and analyze the factors influencing readmission. Association rule analysis and random walk evaluation models were used to evaluate the correlations among HQC treatment, inflammation indicators, and self-perception of patients (SPP) scale.Results: After PSM, 3423 patients were enrolled, with 1142 in the HQC group and 2281 in the non-HQC group. The readmission risk of the HQC group was significantly lower than that of the non-HQC group. Combined univariate and multivariate analysis results revealed that risk factors for readmission were age > 60 years, female sex, hypertension, chronic gastritis, and elevated levels of laboratory indices, including anticyclic citrullinated peptide and complement component 3 (C3) and C4. HQC, disease-modifying antirheumatic drugs, nonsteroidal anti-inflammatory drugs, and glucocorticoid therapy were protective factors for readmission. HQC treatment was closely associated with improvements in many factors, including erythrocyte sedimentation rate, C-reactive protein, C3, rheumatoid factor levels, visual analog scale, depression self-assessment scale, and patient-reported activity index scores with RA.Conclusion: HQC treatment can reduce the risk of readmission and significantly improve immune inflammatory indicators and SPP in patients with RA, with no risk of hepatorenal toxicity.Keywords: Huangqin Qingre Chubi capsule, traditional Chinese medicine, rheumatoid arthritis, readmissionhttps://www.dovepress.com/huangqin-qingre-chubi-capsule-is-associated-with-reduced-risk-of-readm-peer-reviewed-fulltext-article-IJGMhuangqin qingre chubi capsuletraditional chinese medicinerheumatoid arthritisreadmission
spellingShingle Hu Y
Liu J
Xin L
Wan L
Qi Y
Li Y
Chen Y
Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
International Journal of General Medicine
huangqin qingre chubi capsule
traditional chinese medicine
rheumatoid arthritis
readmission
title Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
title_full Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
title_fullStr Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
title_full_unstemmed Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
title_short Huangqin Qingre Chubi Capsule is Associated with Reduced Risk of Readmission in Patients with Rheumatoid Arthritis: A Real-World Retrospective Cohort Study
title_sort huangqin qingre chubi capsule is associated with reduced risk of readmission in patients with rheumatoid arthritis a real world retrospective cohort study
topic huangqin qingre chubi capsule
traditional chinese medicine
rheumatoid arthritis
readmission
url https://www.dovepress.com/huangqin-qingre-chubi-capsule-is-associated-with-reduced-risk-of-readm-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT huy huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT liuj huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT xinl huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT wanl huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT qiy huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT liy huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy
AT cheny huangqinqingrechubicapsuleisassociatedwithreducedriskofreadmissioninpatientswithrheumatoidarthritisarealworldretrospectivecohortstudy